![]() |
Inclusion completed |
Open-label, uncontrolled phase II trial of intravenous PI3K inhibitor BAY-80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin´s lymphomasCancer type: Lymphoma Phase: II Principal Investigator: Leppä Sirpa Country: FI Keywords: Finland, Lymphoma Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/record/NCT01660451 |